(Q44898212)

English

Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Désirée van der Heijde

4

object named as

Désirée van der Heijde

0 references

Robert Landewé

1

object named as

Robert Landewé

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sjef van der Linden

7

object named as

Sjef van der Linden

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Piet Geusens

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Maarten Boers

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Willem Lems

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Johan te Koppele

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Patrick Garnero

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Arthritis & Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

50

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1390-1399

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Predictors of radiographic joint damage in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Molecular basis and clinical use of biochemical markers of bone, cartilage, and synovium in joint diseases

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Cartilage turnover assessed with a newly developed assay measuring collagen type II degradation products: influence of age, sex, menopause, hormone replacement therapy, and body mass index

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Collagen type II C-telopeptide fragments as an index of cartilage degradation

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1002%2FART.20222

21 January 2018

Identifiers

10.1002/ART.20222

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44898212&oldid=2056177244"